Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Equipment
  3. malta
  4. patients enrolled
Show results for
Products
Services
Software
Applications

Companies


Refine by
Locations
Back to All Locations

  • Europe
  • Malta
Brands

  • systimmune
  • acrobiosystems
  • aobiome
  • ariana
  • atheart resept
View all brands
Applications

  • Drug Dolution for Liver Metastases
  • Drug Dolution for Gastric Cancer
  • Microbiota for Restoration Therapy
  • Microbiota Based Product for Physician-Sponsored Studies
  • Microbiome Therapeutics for Patients and Physicians
  • Remote Patient Monitoring Solution for Remote Patient Monitoring
  • Remote Patient Monitoring Solution for Revenue Cycle Management
  • Remote Patient Monitoring Solution for EHR Integration

Patients Enrolled Equipment & Supplies In Malta

33 equipment items found
Available In MaltaNear Malta

Biocartis - Model ctKRAS - Fully Automated Mutation Test Covers System

Biocartis - Model ctKRAS - Fully Automated Mutation Test Covers System

Manufactured by:Biocartis NV   based inMechelen, BELGIUM
IdyllaTM ctKRAS covers 21 KRAS mutations in exons 2,3 and 4 and showed an high concordance to NGS of 96% using plasma samples from 198 mCRC patients enrolled in the prospective multicenter RASANC ...
CONTACT SUPPLIER

Longenesis - Model Engage - Digital Patient Engagement Platform

Longenesis - Model Engage - Digital Patient Engagement Platform

Manufactured by:Longenesis   based inRiga, LATVIA
Collect Real World Data and patient outcomes; Longenesis.Engage is a digital patient engagement platform that enables the benefits of digital approach to patient engagement and research execution. Conduct multiple research projects, funnel patient cohorts for upcoming studies, follow-up and re-engage the participants, and manage their consent while upholding the data protection regulations and ...
CONTACT SUPPLIER

SystImmune - Model BL-B01D1-ADC - Specificity Enhanced Bi-specific Antibody (SEBA) Molecules

SystImmune - Model BL-B01D1-ADC - Specificity Enhanced Bi-specific Antibody (SEBA) Molecules

Manufactured by:SystImmune Inc.   based inRedmond, WASHINGTON (USA)
Built on the foundation of Specificity Enhanced Bi-specific Antibody (SEBA) molecules the SEBA-ADC have an advanced mechanism of action. This advanced functional class is referred to as Heterogeneity overcoming - Immunogenic death inducing - Resistance antagonizing - Enhanced Specificity (HIRE) molecules that target cancer cells. While HIRE molecules provide cancer cells specific targeting, and ...
CONTACT SUPPLIER

atHeart reSept - ASD Occluder Device

atHeart reSept - ASD Occluder Device

Manufactured by:atHeart Medical   based inBaar, SWITZERLAND
Defects vary in size. Some may close on their own early in life, while others require an intervention. Today, the vast majority are performed through minimally invasive catheter-based interventions. They consist in implanting an atrial septal occluder through a transcatheter procedure to close the defect. Current ASD occluder devices have dense metal frames that permanently clamp the septum. The ...
CONTACT SUPPLIER

AOBiome - Therapeutic AOB Pipeline

AOBiome - Therapeutic AOB Pipeline

Manufactured by:AOBiome Therapeutic, LLC   based inCambridge, MASSACHUSETTS (USA)
We have completed six Phase 2 clinical programs and multiple pre-clinical programs. Over 1,000 patients have been enrolled in our clinical trials since 2016. All of those patients except for 28 in our open label pediatric study have been enrolled in randomized double-blind placebo controlled clinical trials evaluating both ...
CONTACT SUPPLIER

Stemline - Model SL-801 - Structurally Novel

Stemline - Model SL-801 - Structurally Novel

by:Stemline Therapeutics, Inc.   based inNew York, NEW YORK (USA)
SL-801’s potential ability to reversibly bind XPO1 may offer the possibility to mitigate side effects and help optimize the therapeutic index. A multicenter Phase 1 dose escalation trial of single agent SL-801 is currently enrolling patients with advanced solid ...
CONTACT SUPPLIER

SystImmune - Model SI-B001 - Specificity Enhanced Bi-specific Antibody (SEBA)

SystImmune - Model SI-B001 - Specificity Enhanced Bi-specific Antibody (SEBA)

Manufactured by:SystImmune Inc.   based inRedmond, WASHINGTON (USA)
The SI-B001 primary mechanism of action is the blocking of EGFR and HER3 signals to cancer cells, and secondarily, through a wt FC receptor mediating innate immune effector functions toward the cancer cells. SI-B001 is currently being evaluated as a single agent in clinical trials enrolling patients with a variety of solid tumor ...
CONTACT SUPPLIER

SystImmune - Model SI-B003 - Tetravalent

SystImmune - Model SI-B003 - Tetravalent

Manufactured by:SystImmune Inc.   based inRedmond, WASHINGTON (USA)
The specificity enhancement both synergistically enhance and expand the breadth of immune cell activity that is diminished in cancer patients (SEBA). The spatio-temporal control of bi-specificity ensure that synergistic blocking of inhibitory receptors is happening in the right place for greatest effect. The tetravalent SI-B003 has two binding domains for T cell checkpoint axis, ...
CONTACT SUPPLIER

Rebiotix - Model RBX2660 - Microbiota Based Product for Clinical Trials

Rebiotix - Model RBX2660 - Microbiota Based Product for Clinical Trials

Manufactured by:Rebiotix Inc., a Ferring Company   based inRoseville, MINNESOTA (USA)
Rebiotix Inc., a Ferring Company, has conducted several trials of the lead microbiota-based product in the MRT drug platform, RBX2660, for reducing the rate of recurrence of Clostridioides difficile infection. RBX2660 is currently under study in a Phase 3 clinical trial in conjunction with the US Food and Drug Administration’s Investigational New Drug ...
CONTACT SUPPLIER

Seres - Model SER-109 C. Difficile - First-In-Class Investigational Microbiome Therapeutic

Seres - Model SER-109 C. Difficile - First-In-Class Investigational Microbiome Therapeutic

Manufactured by:Seres Therapeutics, Inc.   based inCambridge, MASSACHUSETTS (USA)
SER-109 is a first-in-class investigational microbiome therapeutic administered orally following antibiotics to reduce recurrence of C. difficile infection (CDI) in patients with recurrent ...
CONTACT SUPPLIER

SystImmune - Model BL-M05D1 - Antibody Drug Conjugates (ADC) Molecules

SystImmune - Model BL-M05D1 - Antibody Drug Conjugates (ADC) Molecules

Manufactured by:SystImmune Inc.   based inRedmond, WASHINGTON (USA)
Antibody Drug Conjugates (ADC) molecules utilize specific antibodies to deliver therapeutic small molecules specifically to cancer cells. ADC are created in cooperation with Bai-Li Pharmaceutical’s R&D Center of Excellence and enable the development of sophisticated chemistries that give this class of drugs their therapeutic payload. This advanced functional class is referred to ...
CONTACT SUPPLIER

SystImmune - Model BL-M11D1-ADC - Antibody Drug Conjugates (ADC) Molecules

SystImmune - Model BL-M11D1-ADC - Antibody Drug Conjugates (ADC) Molecules

Manufactured by:SystImmune Inc.   based inRedmond, WASHINGTON (USA)
Antibody Drug Conjugates (ADC) molecules utilize specific antibodies to deliver therapeutic small molecules specifically to cancer cells. ADC are created in cooperation with Bai-Li Pharmaceutical’s R&D Center of Excellence and enable the development of sophisticated chemistries that give this class of drugs their therapeutic payload. This advanced functional class is referred to ...
CONTACT SUPPLIER

OpRegen - Advanced Dry Age-Related Macular Degeneration (Dry AMD)

OpRegen - Advanced Dry Age-Related Macular Degeneration (Dry AMD)

Manufactured by:Lineage Cell Therapeutics, Inc.   based inCarlsbad, CALIFORNIA (USA)
On December 20, 2021, Lineage announced that it has entered into an exclusive worldwide collaboration and license agreement with Roche and Genentech, a member of the Roche Group, for the development and commercialization of OpRegen for the treatment of ocular disorders, including advanced dry age-related macular degeneration (dry AMD) with geographic atrophy (GA) in a transaction worth up to $670 ...
CONTACT SUPPLIER

Galapagos - Model Filgotinib - Galapagos Using Our Proprietary Target and Drug Discovery Technology Platform

Galapagos - Model Filgotinib - Galapagos Using Our Proprietary Target and Drug Discovery Technology Platform

Manufactured by:Galapagos NV   based inMechelen, BELGIUM
Filgotinib, a preferential JAK1 inhibitor, is marketed as Jyseleca in the European Union (incl. Norway), Great Britain, and Japan for the treatment of adults with moderately to severely active rheumatoid arthritis (RA) who have responded inadequately or are intolerant to one or more disease modifying anti-rheumatic drugs ...
CONTACT SUPPLIER

SystImmune - Model BL-M07D1-ADC - Antibody Drug Conjugates (ADC) Molecules

SystImmune - Model BL-M07D1-ADC - Antibody Drug Conjugates (ADC) Molecules

Manufactured by:SystImmune Inc.   based inRedmond, WASHINGTON (USA)
Antibody Drug Conjugates (ADC) molecules utilize specific antibodies to deliver therapeutic small molecules specifically to cancer cells. ADC are created in cooperation with Bai-Li Pharmaceutical’s R&D Center of Excellence and enable the development of sophisticated chemistries that give this class of drugs their therapeutic payload. This advanced functional class is referred to as ...
CONTACT SUPPLIER

Vedanta - Model VE416 - Orally Administered Rationally-Defined Bacterial Drug

Vedanta - Model VE416 - Orally Administered Rationally-Defined Bacterial Drug

Manufactured by:Vedanta Biosciences, Inc   based inCambridge, MASSACHUSETTS (USA)
VE416 is an orally administered rationally-defined bacterial consortium candidate being developed for the potential treatment of food allergy. VE416 consists of clonal human commensal bacterial strains selected for their ability to suppress allergic responses and manufactured under cGMP conditions. It is produced from pure, non-pathogenic clonal bacterial cell banks, which yield a standardized ...
CONTACT SUPPLIER

SystImmune - Model GNC-038 - Guidance and Navigation Control (GNC) Molecules

SystImmune - Model GNC-038 - Guidance and Navigation Control (GNC) Molecules

Manufactured by:SystImmune Inc.   based inRedmond, WASHINGTON (USA)
Guidance and Navigation Control (GNC) molecules are multi-specific cell engager proteins. GNC in the oncology therapeutics class bind to cancer cells and to immune cells and stimulate the immune cell cancer killing activity. By design, each GNC molecule is multi-function. In the process of killing, the GNC is designed to educate and empower the T cells to be more effective at killing ...
CONTACT SUPPLIER

SystImmune - Model BL-M02D1-ADC - Antibody Drug Conjugates (ADC) Molecules

SystImmune - Model BL-M02D1-ADC - Antibody Drug Conjugates (ADC) Molecules

Manufactured by:SystImmune Inc.   based inRedmond, WASHINGTON (USA)
Antibody Drug Conjugates (ADC) molecules utilize specific antibodies to deliver therapeutic small molecules specifically to cancer cells. ADC are created in cooperation with Bai-Li Pharmaceutical’s R&D Center of Excellence and enable the development of sophisticated chemistries that give this class of drugs their therapeutic payload. This advanced functional class is referred to ...
CONTACT SUPPLIER

Visaris - Model 360 PACS-RIS - Radiology Workstations

Visaris - Model 360 PACS-RIS - Radiology Workstations

Manufactured by:Visaris Americas a Division of First Source Company   based inRochester, NEW YORK (USA)
Visaris360 incorporating an efficient, scalable digital PACS archive, powerful and ergonomic diagnostic radiology workstations and a streamlined and efficient radiology workflow system (RIS) is an integrated suite of radiology workflow tools covering the complete diagnostic process from exam planning and scheduling to diagnostic finding distribution. Offering a high level of automation and ...
CONTACT SUPPLIER

TransMedics - Model OCS Heart - Organ Care System

TransMedics - Model OCS Heart - Organ Care System

Manufactured by:TransMedics, Inc.   based inAndover, MASSACHUSETTS (USA)
The Only Heart Device Currently Under FDA Review for Utilized and Unutilized Donor Organs. The OCS Heart is a portable, warm perfusion, and monitoring system designed to keep a donor heart at a human-like, metabolically active state. By monitoring key parameters of the functioning heart, physicians may use their medical judgement to assess a potentially suitable heart’s condition and ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT